Syringe components market projected to reach 168 by 2035
Understand this event
IndexBox published a report offering a long-term forecast for the global syringe components market. Using 2025 as the base year, with the index set at 100, the report projects that the market will reach 168 by 2035, equivalent to a compound annual growth rate of 5.3%. It attributes growth to rising demand for biologics and biosimilars, the trend toward patient self-injection, and the shift toward combination products. By end use, subcutaneous delivery is the largest application, with an approximately 45% share. The report also notes that market value will shift toward polymer components such as COP/COC and safety-engineered devices, while Asia-Pacific remains the largest production and sales hub. No subsequent reports are currently available; the above figures are the latest forecast data.
AI 根据报道生成 · 6 days ago更新
Impact and actions
AI compilation of public coverage, separating facts, inference and scenarios. Verify rules against the original sources.
IndexBox forecasts the syringe components market index to reach 168 by 2035
First update · Latest update (Beijing time)
Impact level
⚪ Background
What happened
IndexBox published the report on October 8, 2026. Using 2025 as the base year with an index of 100, it forecasts the global syringe components market to reach 168 by 2035, a compound annual growth rate of 5.3%. Growth is driven by demand for biologics and biosimilars, patient self-injection, and the shift toward combination products. Subcutaneous delivery is the largest end-use application, with an approximately 45% share. Value is expected to shift toward COP/COC polymer components and safety-engineered devices, while Asia-Pacific remains the largest production and sales hub. The report assumes no major supply chain disruptions. [1]
Involves:Syringe components (barrels, plungers, needles, safety devices)、Prefilled syringes、Autoinjectors、COP/COC polymer components
Seller impact
- InferenceThis is a long-term forecast, not a current pricing event. The report says supply and demand bottlenecks involve specialty glass tubing, polymers, and elastomers; qualification cycles are long and switching costs are high. Pricing power lies with suppliers able to offer integrated device platforms. There is no data on short-term prices or lead times, so no inference can be made. [1]
- InferenceFor sellers, the report provides no marketplace rules, tax rates, or procurement quotes, and does not cover 1688 quotes or the share of BOM costs. Therefore, the impact on seller costs, pricing, or cash flow cannot be quantified. It can only be viewed as a medium-term shift in material composition from glass to COP/COC. [1]
Suggested action
Low-cost verification: Consult the original IndexBox report to confirm the base year, CAGR, and definition of the end-use share; do not adjust procurement or quotes based on this alone.
Evidence that would disprove the assessment
- Assessment 1：Public data showing expansion in specialty glass tubing or polymer capacity, or shorter lead times, would indicate that the bottleneck assessment no longer holds. Recommend reviewing it within the next two weeks.
- Assessment 2：Disclosure of specific raw material prices or the share of component BOM costs could overturn the assessment that the impact cannot be quantified.
Coverage timeline
Follow coverage to understand different perspectives.
- IndexBox Industry Chain and Raw MaterialsOriginal ↗Syringe Components Market Forecast for 2035: Demand for Biologics and the Self-Injection Trend to Accelerate Growth
An IndexBox report projects that the global syringe components market, indexed at 100 in the 2025 base year, will reach 168 by 2035, representing a compound annual growth rate of 5.3%. Growth is driven by demand for biologics and biosimilars, patient self-injection, and the shift toward combination products. Subcutaneous delivery is the largest end-use application, with an approximately 45% share. Market value will shift toward polymer components such as COP/COC and safety-engineered devices, while Asia-Pacific remains the largest production and sales hub.
Interest trend for this event
Current interest 3·Comparable scope peak 9（10/9 07:00）·Change over 24 hours within comparable scope -51%
Trends compare the same continuously observed entities, which may be fewer than the current interest count. Move the pointer or select the chart to see hourly values; use arrow keys to navigate.